DREDGECAP
NYSE·Biological Products, (No Diagnostic Substances)
PTHS

Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc. (ticker: PTHS) is an NYSE-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of PTHS's SEC filings surfaces 2 active risk signals, including 1 auditor-change signal, and 1 late-filing signal. PTHS reported $10.91M in revenue and -$10.24M for the period ending 2026-03-31, with operating cash flow of -$13.13M. Cash and equivalents stood at $31.98M (up 24309.2% year-over-year). Total assets of $145.38M exceed total liabilities of $110.28M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

PTHS Risk Flags

Consolidated view of every risk_flag row PTHShas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

CategorySeveritySourceExcerptEDGAR
Late FilingmediumNT 10-K · Apr 1, 2024Form NT 10-K filed 2024-04-01 (accession 0001753926-24-000651) notified the SEC of delayed 10-K filing for period ending 2023-12-31. Substantive filing landed 2024-04-16 (accession 0001753926-24-000740), 17 days after the 2024-03-30 filing …view ↗
Auditor Changelow10-K · Mar 19, 2026PCAOB-tagged auditor in 10-K filed 2026-03-19 (accession 0001919246-26-000013) was 'CBIZ CPAs P.C.' (PCAOB Firm ID: 199). Prior 10-K filed 2025-03-27 (accession 0001753926-25-000503) was 'Marcum LLP' (PCAOB Firm ID: 688).view ↗

Related on PTHS

Auditor & opinion →
Source for auditor_change + going-concern flags.
Share-count dilution →
Source for dilution + convertible-debt flags.
Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.